ConductScience.org, home

Paper7076005

Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.

Maudgal DP and 2 others. Gut, 1982. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet. Papers, record 7076005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7076005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.
PubMed
Journal
Gut
PubMed
Year
1982
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.12
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Maudgal DPD P
2Kupfer RMR M
3Northfield TCT C

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chenodeoxycholic AcidMajor topic
CholelithiasisMajor topic
Cholesterol, DietaryMajor topic
Adult
Aged
Bile
Cholesterol
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Male
Middle Aged

Source PubMed

Download CSV of topics

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15645851The physicochemical basis of cholesterol gallstone formation in man.J Clin Invest1968https://conductscience.org/library/papers/5645851PubMed
25104113The solubility of cholesterol in aqueous solutions of bile salts and lecithin.Z Ernahrungswiss1971https://conductscience.org/library/papers/5104113PubMed
35006919Dissolution of cholesterol gallstones by chenodeoxycholic acid.N Engl J Med1972https://conductscience.org/library/papers/5006919PubMed
44117706Gallstone dissolution in man using chenodeoxycholic acid.Lancet1972https://conductscience.org/library/papers/4117706PubMed
54703231Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man.J Clin Invest1973https://conductscience.org/library/papers/4703231PubMed
64580472Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.N Engl J Med1973https://conductscience.org/library/papers/4580472PubMed
74746773Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates.Gastroenterology1973https://conductscience.org/library/papers/4746773PubMed
84135688Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones.Lancet1974https://conductscience.org/library/papers/4135688PubMed
91152936Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.N Engl J Med1975https://conductscience.org/library/papers/1152936PubMed
101178813Chenodeoxycholic acid therapy for gallstones: effectiveness, toxicity and influence on bile acid metabolism.Q J Med1975https://conductscience.org/library/papers/1178813PubMed
111183049Enzymatic determination of cholesterol in bile.Clin Chim Acta1975https://conductscience.org/library/papers/1183049PubMed
1274722Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action.Lancet1977https://conductscience.org/library/papers/74722PubMed
13709092Low-cholesterol diet: enhancement of effect of CDCA in patients with gall stones.Br Med J1978https://conductscience.org/library/papers/709092PubMed
14435882Optimal timing of doses of chenic acid in patients with gall stones.Br Med J1979https://conductscience.org/library/papers/435882PubMed
1513641241Phosphorus assay in column chromatography.J Biol Chem1959https://conductscience.org/library/papers/13641241PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
38318932Modified dietary fat intake for treatment of gallstone disease in people of any age.Cochrane Database Syst Rev2024https://conductscience.org/library/papers/38318932PubMed
7514975Pharmacological treatment of gallstones. Practical guidelines.Drugs1994https://conductscience.org/library/papers/7514975PubMed
7140487Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet.Dig Dis Sci1982https://conductscience.org/library/papers/7140487PubMed
7009140Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.Drugs1981https://conductscience.org/library/papers/7009140PubMed
6849734Effect of sodium acetyl salicylate on cholesterol saturation of fasting gall bladder bile, with and without chenic acid.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6849734PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7076005

GET https://conductscience.org/api/papers/v1/7076005/authors